-
- EXPLORE
-
-
-
© 2024 IndiCouple - A place for Couples around the world Deutsch
Jüngste Beiträge
- Organoid Construct Kit to Advance Drug DiscoveryCD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its Organoid Construct Kits to the scientific community to facilitate the construction of complex organoid models, enabling researchers to advance drug discovery and development, disease modeling, and personalized medicine. Organoids are microscopic organ-like...0 Kommentare 0 Anteile 789 AnsichtenPlease log in to like, share and comment!
- Stable-Isotope Labeled Particles for Blood Flow MeasurementWith years of experience in the pharmaceutical and life science sectors, CD Bioparticles is excited to announce the launch of its new line of Stable-Isotope Labeled Particles to the scientific community, providing scientists and researchers with a powerful tool for a wide range of applications, including regional organ blood flow measurements and particle deposition studies. Polystyrene...0 Kommentare 0 Anteile 777 Ansichten
- Customized Liposomes for Targeted DeliveryCD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is proud to announce its expanded capabilities in Customized Liposomes. This advancement allows researchers and developers to leverage the power of liposome technology for a wider range of applications. Liposomes are small spherical artificial vesicles (typically 50-500 nm in diameter) composed...0 Kommentare 0 Anteile 1193 Ansichten
- Multi-Analyte Detection with Advanced Multiplex ParticlesWith years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also...0 Kommentare 0 Anteile 1225 Ansichten
-
Mehr Artikel